E. Deneuville

Centre Hospitalier Universitaire de Rennes — France

Medicine · Health Sciences

10h-index370citations62works0.52yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(35), Neonatal Respiratory Health Research(17), Tracheal and airway disorders(12), Pediatric health and respiratory diseases(8), Esophageal and GI Pathology(5)

Publications61 total

P383 Incidence of cystic fibrosis in Brittany (western France): overview of 50 years of monitoring and 35 years of newborn screening
Journal of Cystic Fibrosis·2025
P091 Pharmacokinetic of elexacaftor/tezacaftor/ivacaftor in the context of fetal cystic fibrosis therapy
Journal of Cystic Fibrosis·2025
EPS2.02A new approach to project survival curves by birth cohort in people with cystic fibrosis, drawing on fifty years of experience in Brittany (Western France)
Journal of Cystic Fibrosis·2025
P149 Beyond the lung. Impact of elexacaftor/tezacaftor/ivacaftor on sinonasal disease in children with cystic fibrosis
Journal of Cystic Fibrosis·2025
Seasonal and climatic influence on respiratory infections in children with cystic fibrosis
Scientific Reports·2024Open Access
504 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in children with CF
Journal of Cystic Fibrosis·2024
689 Triple CFTR modulator combination improves glucose tolerance in adolescents with cystic fibrosis: data from the French observational pediatric study MODUL-CF
Journal of Cystic Fibrosis·2024
WS15.03 Elexacaftor/tezacaftor/ivacaftor population pharmacokinetics in paediatric patients with cystic fibrosis
Journal of Cystic Fibrosis·2024
EPS6.02 Striking evolution of survival of cystic fibrosis patients in Brittany (western France): an analysis of the last 50 years by birth cohort
Journal of Cystic Fibrosis·2024
P286 Triple CFTR modulator combination improves glucose tolerance in adolescents with cystic fibrosis. Data from the French observational paediatric study MODUL-CF
Journal of Cystic Fibrosis·2024
P102 Clear illustration of improved survival in cystic fibrosis using the Kaplan-Meier method: the 50-year experience of Brittany, France
Journal of Cystic Fibrosis·2023Open Access
Soins de support chez les enfants atteints de mucoviscidose : comment s’est-on écarté de l’AMM ?
Le Pharmacien Clinicien·2022
Les droits et libertés fondamentaux en période de crise sanitaire
SPIRE - Sciences Po Institutional REpository·2022
WS23.1 Time trends in the incidence of cystic fibrosis: review of the 40-year experience of Brittany (France) and comparison with other regions worldwide
Journal of Cystic Fibrosis·2020Open Access
P003 The diffusion processes of the CFTR mutations in Brittany (France)
Journal of Cystic Fibrosis·2020Open Access
WS16-1 Analysis of time trends in incidence of cystic fibrosis in Brittany (western France) 30 years after implementation of newborn screening in that area
Journal of Cystic Fibrosis·2019Open Access
Dépistage néonatal de la mucoviscidose en France : aspects pratiques et perspectives
Perfectionnement en Pédiatrie·2019· 2 cited
Guidelines for the clinical management and follow-up of infants with inconclusive cystic fibrosis diagnosis through newborn screening
Archives de Pédiatrie·2017· 29 cited
159 Pneumocystis jirovecii and cystic fibrosis in Britanny, France
Journal of Cystic Fibrosis·2017
Intérêt prédictif du score de Wang sur la durée d’oxygénothérapie dans la bronchiolite du nourrisson
Archives de Pédiatrie·2017· 1 cited
page 1 of 4Next →

Frequent Co-authors

M. Roussey(18), G. Rault(9), C. Belleguic(9), Virginie Scotet(8), M. Dagorne(8), J. Beucher(7), Isabelle Sermet‐Gaudelus(6), A. Dabadie(6), M.‐P. Audrézet(6), Claude Férec(6), V. Storni(6), Nathalie Wizla(5), C. L’Hostis(5), Stig Ramel(5), A. Dabadie(4), S. Bui(4), À. Munck(4), J. Brouard(4), Stéphanie Guillot(4), Valérie David(4)